Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8


Novel Method for Rapid Detection of Spatiotemporal HIV Clusters Potentially Warranting Intervention.

Fitzmaurice AG, Linley L, Zhang C, Watson M, France AM, Oster AM.

Emerg Infect Dis. 2019 May;25(5):988-991. doi: 10.3201/eid2505.180776.


Contributions of the US Centers for Disease Control and Prevention in Implementing the Global Health Security Agenda in 17 Partner Countries.

Fitzmaurice AG, Mahar M, Moriarty LF, Bartee M, Hirai M, Li W, Gerber AR, Tappero JW, Bunnell R; GHSA Implementation Group.

Emerg Infect Dis. 2017 Dec;23(13). doi: 10.3201/eid2313.170898.


Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease.

Fitzmaurice AG, Rhodes SL, Cockburn M, Ritz B, Bronstein JM.

Neurology. 2014 Feb 4;82(5):419-26. doi: 10.1212/WNL.0000000000000083. Erratum in: Neurology. 2014 Nov 11;83(20):1880.


Pesticides that inhibit the ubiquitin-proteasome system: effect measure modification by genetic variation in SKP1 in Parkinson׳s disease.

Rhodes SL, Fitzmaurice AG, Cockburn M, Bronstein JM, Sinsheimer JS, Ritz B.

Environ Res. 2013 Oct;126:1-8. doi: 10.1016/j.envres.2013.08.001. Epub 2013 Aug 27.


Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease.

Fitzmaurice AG, Rhodes SL, Lulla A, Murphy NP, Lam HA, O'Donnell KC, Barnhill L, Casida JE, Cockburn M, Sagasti A, Stahl MC, Maidment NT, Ritz B, Bronstein JM.

Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):636-41. doi: 10.1073/pnas.1220399110. Epub 2012 Dec 24.


A novel "molecular tweezer" inhibitor of α-synuclein neurotoxicity in vitro and in vivo.

Prabhudesai S, Sinha S, Attar A, Kotagiri A, Fitzmaurice AG, Lakshmanan R, Ivanova MI, Loo JA, Klärner FG, Schrader T, Stahl M, Bitan G, Bronstein JM.

Neurotherapeutics. 2012 Apr;9(2):464-76. doi: 10.1007/s13311-012-0105-1. Erratum in: Neurotherapeutics. 2012 Apr;9(2):486. Lakshmanan, Ravi [corrected to Lakshmanan, Rajeswari].


Mechanisms of rotenone-induced proteasome inhibition.

Chou AP, Li S, Fitzmaurice AG, Bronstein JM.

Neurotoxicology. 2010 Aug;31(4):367-72. doi: 10.1016/j.neuro.2010.04.006. Epub 2010 Apr 22.


Ziram causes dopaminergic cell damage by inhibiting E1 ligase of the proteasome.

Chou AP, Maidment N, Klintenberg R, Casida JE, Li S, Fitzmaurice AG, Fernagut PO, Mortazavi F, Chesselet MF, Bronstein JM.

J Biol Chem. 2008 Dec 12;283(50):34696-703. doi: 10.1074/jbc.M802210200. Epub 2008 Sep 25.

Supplemental Content

Loading ...
Support Center